Phase III randomized trial comparing neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma.

Autor: Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Patil VM; Department of Medical Oncology, P D Hinduja Hospital & Medical Research Centre, Mumbai, Khar & Mahim., Menon N; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shah MJ; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Singh A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Goud S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shah S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., More S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Nawale K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Nakti D; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Yadav A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jogdhankar S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar R; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Tiwari VK; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Niyogi D; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Janu A; Department of Radiodiagnosis, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Chakrabarty N; Department of Radiodiagnosis, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Mahajan A; Department of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdon and Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom., Tibdewal A; Department of Radiation Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Agarwal J; Department of Radiation Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Pawar A; Department of Biostatistics, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Chowdhury OR; Department of Biostatistics, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Sharma V; Department of Medical Oncology, Yatharth Superspeciality Hospital, Noida Extension, Uttar Pradesh, India., Kapu V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Trika M; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar SV; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kolkur M; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Bhagyavant P; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Peelay Z; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Khedkar R; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Jain M; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Badwe R; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.

Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors.

Autor: Choudhary AK; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Abraham G; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Menon N; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Mandal T; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Jacob S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Garg K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Sekar A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Sarma RJ; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Reddy L; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Nakti D; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Mittal N; Department of Pathology, Tata Memorial Hospital, Mumbai, India., Bal M; Department of Pathology, Tata Memorial Hospital, Mumbai, India., Rane S; Department of Pathology, Tata Memorial Hospital, Mumbai, India., Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai, India., Mahajan A; Department of Radiology, Tata Memorial Hospital, Mumbai, India., Sable N; Department of Radiology, Tata Memorial Hospital, Mumbai, India., Kumar S; Department of Radiology, Tata Memorial Hospital, Mumbai, India., Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.

Publikováno v: Indian journal of surgical oncology [Indian J Surg Oncol] 2022 Mar; Vol. 13 (1), pp. 81-86. Date of Electronic Publication: 2021 Oct 29.

The role of chemotherapy in patients with small cell lung cancer and poor performance status.

Autor: Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Ravind R; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Mokal S; Homi Bhabha National Institute (HBNI), Mumbai, India.; Clinical Research Secretariat, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Menon N; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Kapoor A; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Mahajan A; Homi Bhabha National Institute (HBNI), Mumbai, India.; Department of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India., Janu A; Homi Bhabha National Institute (HBNI), Mumbai, India.; Department of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India., Nakti D; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Shah L; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Shah S; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.; Homi Bhabha National Institute (HBNI), Mumbai, India.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Dec; Vol. 59 (12), pp. 1520-1527. Date of Electronic Publication: 2020 Sep 12.

Efficacy and Safety of Induction Chemotherapy in Esophageal Cancer with Airway Involvement.

Autor: Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India., Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India., Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai, India., Jiwnani S; Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India., Ghosh-Laskar S; Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India., Nakti D; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India., Bandekar B; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Dr. E Borges Marg, Parel, Mumbai, 400012, India. kumarprabhashtmh@gmail.com.

Publikováno v: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2016 Sep; Vol. 47 (3), pp. 294-304.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.